1. Introduction {#sec0005}
===============

Along with the outbreak of the epidemic of 2019 novel coronavirus (COVID-19), the number of older patients infected with COVID-19 was increasing in the world and it brought a serious threat to life and health. A study in the New English Journal of Medicine (NEJM) by Guan reported the clinical characteristics of coronavirus diseases 2019 in China that the rate of older patients older than 65 years with COVID-19 infection was 15.1 % ([@bib0030]), while the proportion of older than 80 years was 3 % reported in the JAMA by Wu and McGoogan ([@bib0110]). It was proved that population including old people was generally susceptible, and the older patients with high infection rate and fatality ([@bib0130]). Unfortunately, the clinical characteristics of COVID-19 infection in older patients is unknown. According to the World Health Organization (WHO) report, as of March 3, 2020, a total of 90,870 cases with laboratory-confirmed with COVID-19 infection have been detected in the world ([@bib0095]). As a new disease and a new global health issue, COVID-19 infection is understandable that its emergence and spread cause anxiety and fear among the older population. In addition, aging population has been one of the largest problems in many countries, and there were a higher prevalence of multimorbidity and lower resistance in older patients ([@bib0025]; [@bib0050]), no doubt, there are many old people who will face the risk of infected with COVID-19 with the globalization and aging population, which imposing a heavy burden on the public and health care systems in the world. Furthermore, the clinical clues that an infection might be present in an older person include fever and some obvious clinical signs, such as fever, cough, and rales, the elder patients may have typical or atypical presentations of infection as that described by the Infectious Diseases Society of America (IDSA) ([@bib0035]), how about the COVID-19 infection? Given that, we collected the data on the 60 older patients infected with laboratory-confirmed COVID-19, described and analyzed the epidemiological and clinical characteristics of the older patients with COVID-19 infection.

2. Methods {#sec0010}
==========

2.1. Participants and settings {#sec0015}
------------------------------

We did a retrospective review of medical records from 60 older patients with COVID-19 infection who was transferred from the general hospitals to the designated hospitals for special treatment infectious diseases by Beijing Emergency Medical Service (EMS) from Jan 20 to Feb 29, 2020. A confirmed case was defined as a suspected cases with the laboratory test for the 2019-nCoV virus from the respiratory specimens show positive result by means of real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) assay, while a suspected case was defined as a case that fulfilled both the following criteria: clinical have fever, radiographic evidence of pneumonia, low or normal white-cell count or low lymphocyte count; and the epidemic history have a travel to Wuhan or direct contact with patients from Wuhan who have fever or respiratory symptoms within 14 days before illness according to the new [@bib0060] which were published by the National Health Commission of China. A mild case was defined as a confirmed case with fever, respiratory symptoms and radiographic evidence of pneumonia. While a severe case was defined as a mild cases with dyspnea or respiratory failure. Only laboratory-confirmed COVID-19 infection was enrolled in this study, laboratory confirmation of COVID-19 was detected in the first admission hospital and verified by the local Center for Disease Control and Prevention (CDC). We collected the data on the demographic, epidemiological, clinical, laboratory tests, diagnosis types, cluster cases and outcomes of COVID-19 infection in elderly patients, and categorized into three groups and compared the difference between middle aged 50--64years, aged 65--79 years and older than 80 years. If the data we need was missing, we directly communicated with EMS providers.

2.2. Ethics {#sec0020}
-----------

The study was approved by Ethics Committee of Beijing Emergency Medical Center (No.2020-01) and the written informed consent was waived.

2.3. Statistical analysis {#sec0025}
-------------------------

All statistical analyses were conducted using the SPSS software version 21.0. The continuous variables were expressed as mean ± SD and were compared with Mann-Whitney U test between two groups. Percentages for categorical variables were analyzed using the Wilcoxon test, although Fisher\'s exact test was used with limited data. P \< 0.05 was the threshold for statistical significance.

3. Results {#sec0030}
==========

There were 60 older patients and 81 middle aged patients identified as confirmed COVID-19 infection in this study by Feb 29, 2020. Of them, 44 patients were categorized into aged 65--79 years group, 16 patients were categorized into older than 80 years group. 34 (56.7 %) patients were male, there were no significant differences between male and female in three groups (χ2 = 2.060, p = 0.151). 31 patients had medical history record information, including hypertension (15, 48.4 %), chronic obstructive pulmonary disease (COPD) (9, 29.0 %), coronary heart disease (5, 16.1 %), diabetes (3, 9.7 %), cerebrovascular disease (2, 6.5 %) and other diseases (8, 25.8 %), there were significant differences between in three groups (χ2 = 8.164, p = 0.004) in medical history, especially COPD in older than 80 years group were significantly higher than those in other two groups (χ2 = 12.024, p \< 0.001).

In this study, the most common symptom of diagnosed confirmed COVID-19 infection in older patients were fever (47, 75 %) and other common symptoms were cough (34, 56.7 %), dyspnea (18, 30.0 %) and fatigue (14, 23.3 %) respectively. The body temperature of 13 (21.7 %) patients were less than 37.3 ℃, while 24 (40.0 %) were between 37 ℃ to 38 ℃, and 23 (38.3 %) were over 38 ℃ ([Table1](#tbl0005){ref-type="table"} ). There were no significant differences in fever and highest temperature between the older patients and middle aged groups (χ2 = 0.006, p = 0.937), but there were significant differences in dyspnea and respiratory rate between two groups (χ2 = 14.597, p \< 0.001).The difference in classification of severity between the two groups was statistically significant (χ2 = 17.31, P \< 0.001), 32 (53.3 %) patients were classified as severe cases, including 13 patients older than 80 years, accounted for 81.3% in this group. Both the number of patients with underlying diseases and the severe patients were increased as aging ([Fig. 2](#fig0010){ref-type="fig"}). Nearly half of the all cases contacted to symptomatic case in 14 days, and older than 80 years group had a higher proportion compared with aged 65--79 years and 50--64 years group (χ2 = 4.804, 0.028). The mean time from contact symptomatic case to illness onset was 7.4 days, from illness onset to visit hospital was 3.6 days, from visit hospital to defined confirmed case was 2.6 days. 36 (60.0 %) and 41 (68.3 %) patients were indigenous cases and clustering cases respectively. By the end of Feb 29, 2020, 32 (53.3 %) older patients are still hospitalized, 23 (38.3 %) were discharged. 5 (8.3 %) patients died. However, the fatality in the aged older than 80 years group was 18.8 %, significantly higher than those in other two groups (χ2 = 7.413, p = 0.025) ([Fig. 1](#fig0005){ref-type="fig"} ).Table 1Characteristics of older patients infected with COVID-19.Table 1Older patientsAge 50--64 y (n = 81)P-valueTotal (n = 60)Age 65--79 y (n = 44)Age ≥ 80 y (n = 16)Male, n(%)34(56.7)26(59.1)8(50)36(44.4)0.151Medical history, n(%)26(n = 31)17(n = 22)9(n = 9)12(n = 25)0.004 Hypertension15(48.4)12(54.5)3(33.3)7(28.0)0.120 Coronary heart disease5(16.1)4(18.2)1(11.1)3(12.0)0.659 COPD9(29.0)3(13.6)6(66.7)0(0.0)0.001 Diabetes3(9.7)3(13.6)0(0.0)2(8.0)0.826 Cerebrovascular disease2(6.5)1(4.5)1(11.1)3(12.0)0.470 Other8(25.8)6(27.3)2(22.2)6(24.0)0.877  Signs and symptoms, n(%) Fever47(78.3)35(79.5)12(75)63(77.8)0.937 Highest temperature,℃0.952\<37.313(21.7)9(20.5)4(25.0)18(22.2)37.3-38.024(40.0)19(43.2)5(31.3)34(42.0)\>38.023(38.3)16(36.4)7(43.8)29(35.8) Cough34(56.7)27(61.4)7(43.8)37(45.7)0.197 Dyspnea18(30.0)14(31.8)4(25.0)5(6.2)\<0.001 Fatigue14(23.3)10(22.7)4(25.0)26(32.1)0.254 Headache4(6.7)3(6.8)1(6.3)7(8.6)0.665 Respiratory rate22.5 ± 5.121.6 ± 5.225.1 ± 4.119.9 ± 3.5\<0.001 Oxygen saturation92.0 ± 6.492.9 ± 4.790.6 ± 8.593.3 ± 2.70.474  Classification of severity, n(%)\<0.001 Mild28(46.7)25(56.8)3(18.8)65(80.2) Severe32(53.3)19(43.2)13(81.3)16(19.8)  History of contact, n(%)47(78.3)33(75)14(87.5)74(91.4)0.028 Have been to Wuhan in 14 days20(33.3)17(38.6)3(18.8)30(37.0)0.327 Contacted to symptomatic case in 14 days28(46.7)17(38.6)11(68.8)45(55.6)0.296 Days from contact to illness onset7.4 ± 4.27.8 ± 4.15.7 ± 5.18.8 ± 5.00.353 Days from illness onset to visit hospital3.6 ± 4.93.9 ± 4.52.4 ± 5.92.8 ± 3.50.294 Days from visit hospital to defined2.6 ± 3.02.5 ± 2.22.9 ± 4.61.9 ± 2.40.126  Distribution, n (%)0.611 Imported cases24(40.0)20(45.5)4(25.0)29(35.8) Indigenous cases36(60.0)24(54.5)12(75.0)52(64.2)  Clustering case, n (%)41(68.3)28(63.6)13(81.3)60(74.1)0.455 Family34(56.7)24(54.5)10(62.5)47(58.0)0.848 Other7(11.7)4(9.1)3(18.8)13(16.0)0.486  Outcomes, n(%)0.025 Hospitalized32(53.3)23(52.3)9(56.3)58(71.6) Discharged23(38.3)19(43.2)4(25.0)22(27.2) Death5(8.3)2(4.5)3(18.8)1(1.2)Fig. 1Distribution of outcomes of COVID-19 infections by age.Fig. 1Fig. 2The distribution of mild, severe and medical history after COVID-19 infection by age.Fig. 2

4. Discussion {#sec0035}
=============

The COVID-19 strokes and as emergencies continued to developing, the WHO declares global emergency on Jan 31, 2020 ([@bib0075]). Older people are more susceptible to a variety of diseases than younger, of course, including COVID-19 infection, which could dramatically increased the healthcare burden under the background of an aging society ([@bib0045]; [@bib0070]). The entire population is susceptible to the COVID-19, and the confirmed patients, asymptomatic carrier and people in the incubation period are contagious, it is difficult to control source of infection ([@bib0120]), and most of the adult patients were old people, who had higher morbidity and case-fatality rate ([@bib0085]). However, the clinical characteristics of COVID-19 infection in older patients were not reported currently. In this study, to our knowledge, we firstly described and analyzed the epidemiological and clinical characteristics of the older patients with COVID-19 infection and compared the difference between aged 50--64 years, aged 65--79 years and older than 80 years groups in Beijing.

In our study, the most common symptom were fever (78.3 %) and cough (56.7 %) in the older patients, which was same as the results of many studies ([@bib0015]; [@bib0030]; [@bib0105]; [@bib0115]; [@bib0125]). Usually, the infected older patients initially have fever, fatigue, dry cough, and gradually appear dyspnea, some patients may develop acute respiratory distress syndrome (ARDS) and septic shock, even die([@bib0010]). 40 % older patients have a fever, the body temperatures were between 37.3--38.0 ℃, and the body temperature of 38.3 % patients were higher than 38.0 ℃, only two patients were over 39 ℃, while not all old patients had fever, 21.7 % old patients were afebrile in our study, which may be caused by old populations with low immune function. The afebrile and low-grade fever, especially older patients, may increase the difficulty to identify and diagnosis COVID-19 in clinical practice if too much attention was given to fever detection, the results same as that described by IDSA.

A research reported that the first death of COVID-19 infection mostly occurred in old people, and developed quickly ([@bib0090]). Existing research found that the overall fatality rate of infected COVID-19 was estimated 2 %--5 % ([@bib0055]; [@bib0040]; [@bib0080]; [@bib0100]; [@bib0110];), however, the case-fatality rate were 8.0 % and 14.8 % in aged 70--79 years and older than 80 years patients respectively ([@bib0110]). The case-fatality rate was 18.8 % of older than 80 years patients in our study, and higher than it mentioned in previous study, which was mainly for the older patients got the more underlying diseases as a result of the weaker immune functions. When old populations were infected with COVID-19, prompting administration of antibiotics to prevent infection and strengthening of immune support treatment might reduce the case-fatality rate ([@bib0010]).

Our study found that number of older patients with underlying diseases were relatively susceptible to COVID-19 and indicated that the infected COVID-19 elderly with relatively high proportion of comorbidities, and the most common comorbidities were hypertension (48.8 %), coronary heart disease (16.1 %), COPD (29.0 %), diabetes (9.7 %) and cerebrovascular disease (6.5 %) respectively, which was in accordance with previous studies ([@bib0010]; [@bib0125]). Latest research stated that the older patients and among those with coexisting conditions had a higher morbidity and case-fatality rate ([@bib0020]; [@bib0065]). COVID-19 confirmed older patients who were older than 65 years with comorbidities were at increased risk of death ([@bib0130])

In our study, severe patients were significantly more than mild patients in older patients, which was similar with recent study that patients have more severe symptom in elderly population ([@bib0005]). Multiple factors lead to a higher proportion of elderly patients with severe situation, such as senior, comorbidities, low immune functions and so on. There is no doubt that old severe patients are more likely to die, therefore, the clinical treatment capacity need to improve to decrease the case-fatality rate of severe patients with COVID-19 infection, and the elderly should be pay special attention. There was a 65-year-old man who was afebrile and well, and noteworthy, he was an asymptomatic case, which is one of the particular features of our study. The proportion of contacted to symptomatic case in 14 days was significantly higher in aged older than 80 years group compared with the aged 65--79 years group in our study, which owing to the aged older than 80 years elderly were mostly accompanied by their families. Familial cluster of infected with COVID-19 have been reported in homes, especially without obvious symptoms. If the asymptomatic and mild cases cannot be found or ignored, they will spread the virus to others quickly. Therefore, to identify and control the infected cases, as well as early quarantine for their close contacts, especially in families are important measures to prevent transmission of the COVID-19 infection in older population.

This study has some limitations. First, only the COVID-19 confirmed older cases transferred by EMS in Beijing were included, the first admission to the designated hospitals cases were not enrolled, nor other provinces or cities which dominated by imported. It would be better to cover as wide population as possible to get more accurate results. Second, the observation time of this study is 39 days, which is still short, many patients need time to further observed. However, this study represents characteristics of early stage of COVID-19 confirmed elderly in Beijing, which has practical significance for the control and research of the older patients.

5. Conclusions {#sec0040}
==============

The older confirmed patients with COVID-19 infection has a high proportion of severe cases, and the COVID-19 infection is generally susceptible with a relatively high fatality rate in older population. We should pay more attention to the older patients.
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